Home/Peptides/O-304 (ATX-304) 100mg x60 Capsules
O-304 (ATX-304) 100mg x60 Capsules
Body Composition
BODY COMPOSITION

Buy O-304 (ATX-304) 100mg x60 Capsules

Pan-AMPK activator for metabolic syndrome, exercise mimicry, and body composition

Verified O-304 (ATX-304) 100mg x60 Capsules — O-304 (ATX-304) is a first-in-class pan-AMPK activator in clinical trials that produces exercise-like metabolic effects — improving insulin sensitivity, reducing fat, and enhancing vascular function.

  • First-in-class pan-AMPK activator in clinical trials
  • Reduces fasting glucose and improves insulin sensitivity
  • Promotes fat oxidation and reduces visceral adiposity
  • Improves vascular function via eNOS activation
  • Oral capsule format for convenient daily dosing
$107.99$119.99
10% OFF
COA Verified · Third-Party Tested
US Domestic Shipping
Buy O-304 (ATX-304) 100mg x60 Capsules on Phiogen

COA verified · US domestic shipping

O-304 (ATX-304): The Pan-AMPK Activator in Clinical Trials for Metabolic Syndrome and Cardiovascular Disease

Pan-AMPK Activation

O-304 activates all AMPK complexes simultaneously — delivering more complete exercise-mimetic metabolic signaling than any previous AMPK-targeting compound.

Clinical Trial Validation

Phase I/IIa data confirms reductions in fasting glucose, improved insulin sensitivity, and visceral fat loss in T2D patients — regulatory-grade evidence for its metabolic efficacy.

Vascular Function Improvement

Beyond metabolic effects, O-304 improves microvascular blood flow via eNOS activation — addressing the vascular component of metabolic syndrome that pure metabolic agents miss.

ADaM Site Binding

O-304 uses AMPK's allosteric activation site (ADaM) — a mechanism that both activates the enzyme and protects its activation from being reversed, sustaining the metabolic signal.

The Science Behind O-304 (ATX-304) 100mg x60 Capsules

The Clinical-Stage Pan-AMPK Activator

O-304 (ATX-304) is a small molecule pan-AMPK activator developed by Betagenon AB, currently in Phase IIb trials for type 2 diabetes and cardiovascular disease. As a "pan" activator, it activates all AMPK heterotrimeric complexes — not just the α2β1γ1 form activated by existing agents — producing a more complete exercise-mimetic metabolic response than any previous AMPK activator.

Mechanism: Comprehensive AMPK Activation

O-304 binds to the ADaM (allosteric drug and metabolite) site on AMPK, activating the enzyme allosterically and protecting it from dephosphorylation simultaneously. Pan-AMPK activation coordinates glucose uptake, fatty acid oxidation, mitochondrial biogenesis, and vascular relaxation (via eNOS activation) — producing a metabolic state that closely mimics sustained aerobic exercise across multiple tissues.

Clinical Evidence

Phase I/IIa trials demonstrated that O-304 significantly reduced fasting glucose, improved insulin sensitivity, reduced visceral fat, and improved peripheral blood flow in type 2 diabetic patients. The concurrent vascular effects — including improved microvascular blood flow — make O-304 particularly relevant for metabolic syndrome, where vascular dysfunction accompanies insulin resistance and obesity.

Complete O-304 (ATX-304) 100mg x60 Capsules Benefits

  • First-in-class pan-AMPK activator in clinical trials
  • Reduces fasting glucose and improves insulin sensitivity
  • Promotes fat oxidation and reduces visceral adiposity
  • Improves vascular function via eNOS activation
  • Oral capsule format for convenient daily dosing
  • Exercise-mimetic effects without physical exertion requirement
  • 60-capsule supply for complete metabolic improvement cycle

O-304 (ATX-304) 100mg x60 Capsules Dosing Protocol

Dosing:

Metabolic improvement: 100mg orally daily with food (per clinical protocol)

Exercise mimicry: 100–200mg daily for 8–12 weeks

Cycle: 12-week cycles aligned with clinical trial protocols

Capsule format: Take with food; clinical trials used once-daily oral dosing

All information on this site is for educational purposes only. Always consult with a qualified healthcare provider before use. COA documentation is available for all products.

O-304 (ATX-304) 100mg x60 Capsules

COA verified · Third-party tested · US domestic shipping

Buy Now View Stack Protocols
Certificate of Analysis (COA)
US Domestic Shipping
COA-Verified Purity
24–48hr Processing
$107.99
$119.99
Body Composition

Body composition peptides optimize the GH/IGF-1 axis and metabolic signaling for simultaneous fat loss and muscle gain.

All Body Composition Peptides

Stack O-304 (ATX-304) 100mg x60 Capsules With

NAD+ 100mgHealing

NAD+ 100mg

Injectable NAD+ for cellular energy, DNA repair, and anti-aging restoration

Verified NAD+ 100mg — Injectable NAD+ 100mg — the coenzyme central to cellular energy metabolism, sirtuin activation, DNA repair, and mitochondrial biogenesis for comprehensive anti-aging support.

NAD+ Anti-Aging Energy
$26.99$29.99
Buy Now
MOTS-c 5mgAnti-Aging

MOTS-c 5mg

Mitochondrial micropeptide for metabolic regulation, exercise adaptation, and longevity

MOTS-c 5mg For Sale — MOTS-c is a mitochondria-encoded peptide that mimics the metabolic effects of exercise, improves insulin sensitivity, reduces obesity, and activates AMPK for longevity signaling.

MOTS-c Mitochondria Metabolic
$116.99$129.99
Buy Now
AICAR 50mgBody Composition

AICAR 50mg

AMPK activator for endurance enhancement, fat oxidation, and metabolic health

Trusted AICAR 50mg — AICAR (AICA ribonucleotide) is an AMPK activator that increases endurance capacity, enhances fat oxidation, and produces metabolic adaptations mimicking aerobic exercise training.

AICAR AMPK Endurance
$62.99$69.99
Buy Now